Biofrontera AG B8FK.DE
€2.32
Last Updated: Aug 13, 12:00 AM·XETRA
Pricing for DE stocks is delayed by 24 hours
B8FK.DE Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Biofrontera AG is classified as halal.
HALAL
Report Source: undefined Quarter Report
Biofrontera AG. Stock Analysis B8FK.DE
Germany Health Care Nano Cap Biofrontera AG engages in the research, development, and marketing of dermatological products. The firm develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itching, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The firm is also engaged in clinical development of two drug candidates: BF-derm1, a tablet with inhibitor blocking the synthesis of histamine in cells, a cause of allergic reactions; and BF1, a selective serotonin receptor to prevent migraines. The firm operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MM Familien KG.
Biofrontera AG (B8FK.DE) Chart
Financial Metrics & Statements of Biofrontera AG (B8FK.DE)
FAQ's for Biofrontera AG (B8FK.DE)
- As of August 2026, Biofrontera AG B8FK.DE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biofrontera AG using these criteria to determine its compliance status.
- Muslim investors may consider investing in Biofrontera AG if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Biofrontera AG by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Biofrontera AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Biofrontera AG on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Biofrontera AG (B8FK.DE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
